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Abstract
Objectives—Evidence-based decision making (EBDM) is the process, in local health 
departments (LHDs) and other settings, of translating the best available scientific evidence into 
practice. Local health departments are more likely to be successful if they use evidence-based 
strategies. However, EBDM and use of evidence-based strategies by LHDs is not widespread. 
Drawing on Diffusion of Innovations theory, we sought to understand how LHD directors and 
program managers perceive the relative advantage, compatibility, simplicity, and testability of 
EBDM.
Design, Setting, and Participants—Directors and program managers in chronic disease, 
environmental health, and infectious disease from LHDs nationwide completed a survey including 
demographic information and questions about diffusion attributes (advantage, compatibility, 
simplicity, and testability) related to EBDM. Bivariate inferential tests were used to compare 
responses between directors and managers and to examine associations between participant 
characteristics and diffusion attributes.
Results—Relative advantage and compatibility scores were high for directors and managers, 
while simplicity and testability scores were lower. Although health department directors and 
managers in chronic disease generally had higher scores than other groups, there were few 
significant or large differences between directors and managers across the diffusion attributes. 
Larger jurisdiction population size was associated with higher relative advantage and 
compatibility scores for both directors and managers.
Conclusions—Overall, directors and managers were in strong agreement on the relative 
advantage of an LHD using EBDM, with directors in stronger agreement than managers. 
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Perceived relative advantage has been demonstrated to be the most important factor in the rate of 
innovation adoption, suggesting an opportunity for directors to speed EBDM adoption. However, 
lower average scores across all groups for simplicity and testability may be hindering EBDM 
adoption. Recommended strategies for increasing perceived EBDM simplicity and testability are 
provided.
Introduction
A primary goal of local health departments (LHDs) is to assure that residents of their 
jurisdiction receive essential public health services.1 Differences in LHD resources,3 
organizational structures,2 partners,3 and local health characteristics4 may influence the 
feasibility of providing services and help to determine which take priority. With 26.5% of 
LHDs reporting budget cuts in 2013, and 28.5% expecting budget cuts in 2014,5 it is critical 
LHDs devote existing resources to effective health promotion and disease prevention 
strategies.
Local health departments are more likely to be successful, and to meet accreditation 
standards, if they use evidence-based strategies.6,7 Interventions not resulting in high health 
returns on investment can be costly to society, especially with the public health system 
facing increasingly limited financial resources.7,8 Evidence-based decision making (EBDM) 
in public health is the process, in LHDs and other settings, of translating the best available 
scientific evidence about program and policy effectiveness into practice while taking into 
consideration local data, resources, and need.7,9,10 The current national voluntary 
accreditation program under the Public Health Accreditation Board (PHAB) includes several 
domains that relate directly or indirectly to EBDM.6 Most directly, Domain 10 requires 
health departments to Contribute to and apply the evidence base of public health, by both 
identifying and using the best available evidence for making informed public health practice 
decisions, as well as promoting understanding and use of EBDM. In addition, several 
domains relate to the process of EBDM, including conducting community health 
assessments (Domain 1); identifying problems, recognizing community context (Domain 4); 
developing policies and plans (Domain 5); and evaluating health department processes, 
programs, and interventions (Domain 9). In addition Domain 11: Maintain administrative 
and management capacity, as well as Domain 8, Maintain a competent public health 
workforce, comprise Administrative-Evidence Based Practices.11 Although informational 
resources such as the Guide to Community Preventive Services summarize existing evidence 
and provide specific recommendations for public health organizations, evidence-based 
decision making and use of evidence-based strategies by LHDs is not widespread.7
Barriers to adopting evidence-based strategies include political environment, a lack of 
relevant research, scarce resources, and characteristics associated with leadership and staff 
experience and expectations.7,9,11,12 In addition to these informational and organizational 
barriers, effective dissemination of evidence-based strategies among LHDs is a significant 
barrier to adoption.12 That is, while health professionals are likely aware of evidence-based 
guidelines, and agree with the idea of evidence-based strategies, relevant evidence is not 
always available to incorporate into public health programming.
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Early work by Becker13,14 and Mohr15 examining diffusion of innovation among LHD 
officers identified several organizational characteristics significantly associated with the 
diffusion process. Becker found that the earliest adopters of innovations varied by age and 
education and information seeking strategies used, while their jurisdictions varied by 
rurality. Those who would adopt less risky interventions were younger, in urban areas, 
recently graduated, and had a higher standing in their graduating class. Those who would 
take more risk and adopt less conventional interventions were older and more established in 
their leadership roles, in rural areas, and had an average standing in their graduating class. 
Mohr found that large health departments were more likely to innovate compared to small 
health departments, due to greater availability of staffing and funding to manage many 
programs.15 Within an organization, leadership and management are important actors in the 
adoption and implementation of innovations. Specifically, leadership often adopts 
innovations, while implementation of innovations relies strongly on the support of manager-
level staff.16Adoption and implementation of an innovation by manager-level staff may be 
encouraged or hindered by aspects of organizational climate, including how decisions are 
made about adoption of innovative practices.16,17 In organizations with highly centralized 
decision-making processes, managers may be excluded from participating in decision-
making, which results in lower levels of implementation of innovations.
Rogers' diffusion of innovation (DOI) theory identifies five factors that influence diffusion 
and adoption of an innovative idea or strategy like EBDM.18 Specifically, to be adopted, an 
innovation must be perceived as offering relative advantage, being compatible, being 
simple, being testable, and being observable.18 Relative advantage is “the degree to which 
an innovation is perceived as better than the idea it supersedes.” Compatibility is “the degree 
to which an innovation is perceived as consistent with existing values, past experiences, and 
needs of potential adopters.” Simplicity is “the degree to which an innovation is perceived as 
relatively difficult to understand.” Testability (or trialability) is “the degree to which an 
innovation may be experimented with on a limited basis.”18 These factors are important at 
the second stage of the adoption process, the persuasion stage, where an individual has 
already been exposed to a new idea and is seeking information about the idea in order to 
move to the next stage and make a decision on adoption.
With the importance of EBDM for effective public health practice, we sought to better 
understand how LHD directors and program managers perceive the relative advantage, 
compatibility, simplicity, and testability of EBDM. This study builds on what we know from 
past research on diffusion and recent work by Erwin and colleagues,19 which described the 
importance of individual and organizational factors in explaining performance of 
administrative evidence-based practices by LHD directors and managers. Specifically, we 
examined and compared LHD directors and managers from three program areas (chronic 
disease, environmental health, and infectious disease) on their perceptions of EBDM and 
examined associations between perceptions and LHD jurisdiction population size, director/
manager age, and director/manager education level.
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Methods
Sampling
The study team developed, tested, and validated a survey instrument to examine EBDM in 
LHDs as part of the LEAD (Local Evidence for Affecting Decisions) Public Health Project 
to identify local evidence for effecting decisions about public health (see http://
prcstl.wustl.edu/ResearchAndFindings/Pages/LEAD-public-health-project.aspx). For the 
analyses reported here, and in Erwin's recent study of administrative evidence-based 
practices,19 a stratified random sample of US LHDs was drawn from the database of the 
National Association of County and City Health Officials. Health departments were drawn 
from five groups, according to jurisdiction population size of a LHD: <25,000, 
25,000-49,999, 50,000-99,999, 100,000-499,999, and 500,000+ persons. A sample of 1,067 
LHDs was used as the initial sample. Next, an online survey was delivered nationally to 
email accounts of 1,067 LHD directors. After excluding non-valid email addresses the final 
sample was 967. Five-hundred thirty-one LHD directors responded to the survey; 14 refused 
to complete the survey, leaving 517 valid responses (54% response rate); 332 program 
managers from three program areas also participated. Program managers were from 196 
LHDs and represented chronic disease (n=99), infectious disease (n=113), and 
environmental health (n=100) (response rates: 59%, 64%, and 56%, respectively). We sent 4 
email reminders and made 2 phone calls to LHD directors and sent 3 email reminders to 
program managers. Several LHDs had two or more program manager participants; to ensure 
independent observations; one program manager from each of these LHDs was randomly 
selected for analysis, for a total of 196 program managers matched with 196 LHD directors. 
The study was approved by the Institutional Review Board at Washington University in St. 
Louis.
We used chi-squared to compare non-responders and responders across jurisdiction 
population size, governance type, and region. We found no significant association between 
response and governance type, however, we found a significant association between 
response and population category (χ2(4)=10.47; p=.03), with standardized residuals 
indicating that practitioners from health departments serving fewer than 25 thousand 
constituents were less likely than expected to respond to the survey. Specifically, the 
response rates were 41.0%, 50.5%, 51.4%, 52.7%, and 52.3% for the five jurisdiction 
population categories in order from smallest to largest: <25,000, 25,000-49,999, 
50,000-99,999, 100,000-499,999, and 500,000+. Likewise, a significant association between 
response and region (χ2(3)=28.04; p<.001) with standardized residuals indicating that fewer 
than expected practitioners from LHDs in the Northeast, but more than expected in the 
Midwest, responded.
Diffusion items
Ten statements were made about the four areas of diffusion (see Table 1); LHD directors 
and program managers were asked to indicate how strongly they agreed with each of the ten 
statements using a seven-point scale from strongly disagree to strongly agree. The 
instrument is available on the Prevention Research Center in St. Louis website (see LEAD 
project URL above). The higher the score, the more strongly the participant agreed with the 
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statement. Note that, for statements 8 and 9 in Table 1, a higher score indicated that the 
director or manager believed many changes or additional staffing would be needed to 
implement EBDM. Higher scores on all other items indicate support for EBDM without 
major changes. We computed scale scores for compatibility, simplicity, and testability by 
taking the mean of the items comprising the score; items 8 and 9 were reverse coded prior to 
computing scale scores to make directionality similar for all items.
Data analysis
A sign test was used to determine whether directors and managers from the same LHD 
differed with respect to age and education. Although diffusion characteristics were measured 
on ordinal scales, responses, and scales resulting from averaging responses, were normally 
distributed, with no large skew or kurtosis identified. Given the large number of categories 
and the relatively normal distribution, paired t-tests were used to determine whether there 
was an association between the scores of directors and program managers overall and from 
each of the three areas in the same LHD. For each significant paired t-test, a measure of 
effect size (Cohen's d) was calculated to determine the magnitude of the difference. In 
addition, associations between diffusion characteristics and LHD jurisdiction size, and 
between diffusion characteristics and individual characteristics of age and education 
categories were examined using Spearman's rho rank-order correlation coefficient and one-
way analysis of variance for both directors and managers. Due to the large number of 
significance tests, we adjusted the alpha for all analyses to.01; results with a p-value at or 
below.01 were considered statistically significant.
Results
Sample characteristics
The median jurisdiction population size for the 196 LHDs included in this analysis was 66.5 
thousand with a range of 950 to 2.2 million. Age and education were different between 
directors and managers, with more directors being in older age categories and higher degree 
categories compared to managers (Table 2).
Relative advantage
There was a significant difference with a small-to-medium effect size (t=4.60; p<.001; d=.
35) between the average relative advantage score for directors (m=6.22; sd=.79) and 
managers overall (m=5.83; sd=.99) in the same LHD (Figure 1). There were no significant 
difference between directors and managers in chronic disease (m=6.07; sd=.76), a 
significant difference with a medium effect size (t=3.63; p=.001; d=.48) between directors 
and managers in environmental health (m=5.60; sd=1.15), and a significant difference with 
medium effect size (t=2.78; p=.008; d=.39) for directors and managers in infectious disease 
(m=5.81; sd=.99). There was also a positive and significant moderate correlation between 
jurisdiction population size and relative advantage for directors (r=.22; p=.002), managers 
overall (r=.25; p=.001), and chronic disease managers (r=.34; p=.008), but not for 
environmental health or infectious disease managers.
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Age was not significantly associated with relative advantage score for directors or managers 
of any type. There was a significant association between education and relative advantage 
score for directors (F=5.10; p=.001) but not for managers of any type. Bonferroni post-hoc 
tests found that directors with a Bachelor's or lower scored significantly lower than those 
having other master's degrees.
Compatibility
There was no significant difference between the average score for directors (m=5.54; sd=.
97) and managers overall (m=5.31; sd=1.14) in the same LHD for compatibility. However, 
while managers in chronic and infectious disease did not differ significantly from their 
directors on compatibility perceptions, compared to directors in the same LHD, managers in 
environmental health (m=5.08; sd=1.22) had significantly lower compatibility scores 
(t=2.76; p=.008; d=.36).
Population size had a positive and significant associations with compatibility for directors 
(r=.18; p=.01), managers in general (r=.21; p=.005), and environmental health managers (r=.
36; p=.005). Age and education had no significant association with score for compatibility 
for directors or any type of manager.
Simplicity
There were no statistically significant differences between the average score for directors 
and managers of all types in the same LHD for simplicity. Population size, age, and 
education had no significant association with scores for simplicity for directors or managers.
Testability
There was a significant difference with a small effect size (t=2.74; p=.007; d=.21) in average 
testability scores between directors (m=4.44; sd=.75) and managers (m=4.25; sd=.74), 
however, there were no significant differences in testability scores between directors and 
managers when each of the three program-related groups (i.e., chronic, infectious, 
environmental) was examined separately. Population size, age, and education had no 
significant association with scores for testability for directors or managers, with the 
exception of a positive and significant correlation between population size and testability for 
environmental health managers (r=.35; p=.007).
Discussion
Overall, both directors and managers were in strong agreement that using EBDM would 
result in positive change, with directors in significantly stronger agreement than managers. 
Directors and manager scores were similar with one another regarding the compatibility, 
simplicity, and testability of EBDM, however, the scores for these elements of diffusion 
were lower than for relative advantage. Responses regarding simplicity and testability were 
lowest and close to neutral near the mid-point of 4 (“Neither agree nor disagree”) on the 7-
point scale. Most differences between directors and managers were not statistically 
significant; however, consistent with chronic disease managers scoring highest in the use of 
administrative evidence-based practice in a related study,19 managers in chronic disease had 
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consistently higher scores compared to other manager types across all diffusion areas, and 
were most consistent with LHD directors. Managers in environmental health had 
consistently lower scores than other managers and LHD directors.
Consistent with early diffusion work by Mohr16 and recent findings from Erwin et al., 19 we 
found significant positive associations between jurisdiction population size and EBDM 
diffusion characteristics (i.e., larger jurisdiction was correlated with larger scores) for 
directors (relative advantage, compatibility), managers overall (relative advantage, 
compatibility), chronic disease managers (relative advantage), and environmental health 
managers (testability). However, contrary to early diffusion studies13-15 the individual-level 
characteristics of age and education level had little to no influence on diffusion attributes.
Perceived relative advantage has been demonstrated to be the most important of the factors 
in predicting the rate of innovation adoption,18,20,21 so high perceived relative advantage is 
promising for the spread of EBDM in LHDs. In addition, the significant difference in 
relative advantage scores between directors and managers suggests two possible strategies 
for improving the diffusion of EBDM: (1) increase encouragement by leadership for EBDM; 
and (2) increase the connections among managers in larger LHDs and their counterparts in 
smaller LHDs. Leaders who devote personal influence to encourage EBDM adoption by 
managers and who work to create a climate supportive of innovation by managers and other 
professional staff may be able to increase innovation in their organizations.16,17,20 
Specifically, because LHD directors have significantly higher relative advantage scores, 
they could work to communicate the relative advantage of EBDM and foster a climate of 
innovation supportive of EBDM across the LHD by including managers in the decision to 
adopt EBDM. Our results suggest it may be especially important for leadership to increase 
communication about the advantages of EBDM in smaller LHDs, particularly with 
environmental health managers. In addition, peer networks may also influence diffusion. A 
recent study of communication ties among LHDs found that ties associated with diffusion 
were more likely between LHDs sharing the same population size, staffing and funding 
levels, and programming types.22 With higher relative advantage scores in larger LHDs, it 
might be useful to develop new communication ties between LHD managers in smaller 
LHDs and their peers at larger LHDs.
Simplicity23,24 and testability25 are also strongly associated with innovation adoption;17,26 
low scores in simplicity and testability across leadership and management in LHDs may 
therefore be barriers to EBDM diffusion. Breaking an innovation down into manageable 
parts for incremental adoption can increase simplicity;25 as can demonstrating the 
innovation.26 Perceived testability is greater if testing can be done slowly or on a small 
scale.17 Breaking EBDM into parts or implementing EBDM on a small scale may require 
partnerships between researchers and practitioners to develop feasible strategies that 
maintain innovation fidelity.27
Limitations
This study is limited by cross-sectional self-reported data. In addition, the response rates for 
LHD directors (54%) and program managers (59%, 64%, and 56% for the three programs) 
were somewhat low and may bias the results. We also had fewer participants than expected 
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from very small and Northeastern health departments and more than expected from 
Midwestern health departments represented, which may have influenced our results. Despite 
these limitations, this study is the first that we know of to examine diffusion attributes for 
EBDM in a range of LHD settings.
Use of EBDM aids in ensuring that LHDs are selecting effective strategies with the best 
public health return on investment. Although use of EBDM is not yet widespread across 
LHDs, our results indicate that directors and program managers in LHDs generally agree 
that EBDM has relative advantage over other strategies. With past research demonstrating 
that relative advantage is the most important of the diffusion factors examined here, our 
findings bode well for EBDM diffusion across LHDs. Strategies to increase perceived 
relative advantage among managers and perceived simplicity and testability among all 
groups may increase the likelihood of EBDM adoption, although recognizing that diffusion 
of an innovation like EBDM is often slow, even when it is perceived as having high relative 
advantage and strategies to encourage diffusion are employed.20
Acknowledgments
Funding: This study was supported in part by Robert Wood Johnson Foundation's grant no. 69964 (Public Health 
Services and Systems Research). This article is a product of a Prevention Research Center and was also supported 
by Cooperative Agreement Number U48/DP001903 from the Centers for Disease Control and Prevention. The 
findings and conclusions in this article are those of the authors and do not necessarily represent the official position 
of the Centers for Disease Control and Prevention. We also thank members of our research team, Peg Allen, Beth 
Dodson, Katie Duggan, Carolyn Leep, Robert Fields, Katie Stamatakis, and Drs. Glen Mays and Douglas 
Scutchfield of the National Coordinating Center for Public Health Services and Systems Research, University of 
Kentucky College of Public Health.
References
1. Mays GP, McHugh MC, Shim K, et al. Getting what you pay for: Public health spending and the 
performance of essential public health services. J Public Health Manag Pract. 2004; 10(5):435–43. 
[PubMed: 15552769] 
2. Beitsch LM, Grigg M, Menachemi N, Brooks RG. Roles of local public health agencies within the 
state public health system. J Public Health Manag Pract. 2006; 12(3):232–241. [PubMed: 
16614558] 
3. Beatty KB, Harris JK, Barnes P. The role of inter-organizational partnerships in health services 
provision among rural, metropolitan, and urban local health departments. Journal of Rural Health. 
2010; 26:248–258. [PubMed: 20633093] 
4. Stamatakis KA, Leatherdale ST, Marx C, Yan Y, Colditz GA, Brownson RC. Where is obesity 
prevention on the map? distribution and predictors of local health department prevention activities 
in relation to county obesity prevalence in the US. Journal of Public Health Management and 
Practice. 2012; 18(5):402–411. [PubMed: 22836530] 
5. National Association of County and City Health Officials. [Accessed June 25,2014] 2013 national 
profile of local health departments. http://www.naccho.org/topics/infrastructure/profile/upload/
2013-National-Profile-of-Local-Health-Departments-report.pdf
6. Public Health Accreditation Board. [Accessed March 16,2014] Standards and measures. http://
www.phaboard.org/wp-content/uploads/PHAB-Standards-Overview-Version-1.0.pdf. Updated 2011
7. Brownson RC, Fielding JE, Maylahn CM. Evidence-based public health: A fundamental concept for 
public health practice. Annual Review of Public Health. 2009; 30:175–201.
8. Fielding JE. Where is the evidence? Annual Review of Public Health. 2001; 22:v–vi.
Harris et al. Page 8
J Public Health Manag Pract. Author manuscript; available in PMC 2015 December 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
9. Jacobs JA, Clayton PF, Dove C, et al. A survey tool for measuring evidence-based decision making 
capacity in public health agencies. BMC Health Services Research. 2012; 12(1):57. [PubMed: 
22405439] 
10. Kohatsu ND, Robinson JG, Torner JC. Evidence-based public health: An evolving concept. Am J 
Prev Med. 2004; 27(5):417–421. [PubMed: 15556743] 
11. Brownson RC, Allen P, Duggan K, Stamatakis KA, Erwin PC. Fostering more-effective public 
health by identifying administrative evidence-based practices: A review of the literature. Am J 
Prev Med. 2012; 43(3):309–319. [PubMed: 22898125] 
12. Brownson RC, Ballew P, Dieffenderfer B, et al. Evidence-based interventions to promote physical 
activity: What contributes to dissemination by state health departments. Am J Prev Med. 2007; 
33(1):S66–S78. [PubMed: 17584593] 
13. Becker MH. Factors affecting diffusion of innovations among health professionals. Am J Public 
Health. 1970; 60(2):294–304.
14. Becker MH. Sociometric location and innovativeness: Reformulation and extension of the 
diffusion model. Am Sociol Rev. 1970:267–282.
15. Mohr LB. Determinants of innovation in organizations. The American Political Science Review. 
1969; 63(1):111–126.
16. Klein KJ, Sorra JS. The challenge of innovation implementation. Academy of management review. 
1996; 21(4):1055–1080.
17. Greenhalgh, T.; Robert, G.; Bate, P.; Macfarlane, F.; Kyriakidou, O. Diffusion of innovations in 
health service organisations: A systematic literature review. Wiley; 2008. 
18. Rogers, EM. Diffusion of innovations, 5th edition. Simon & Schuster; 2003. 
19. Erwin PC, Harris JK, Smith C, Leep CJ, Duggan K, Brownson RC. Evidence-based public health 
practice among program managers in local public health departments. J Public Health Manag 
Pract. 2013 [doi]. 10.1097/PHH.0000000000000027
20. Rogers EM. Diffusion of preventive innovations. Addict Behav. 2002; 27(6):989–993. [PubMed: 
12369480] 
21. Lock CA, Kaner EF. Use of marketing to disseminate brief alcohol intervention to general 
practitioners: Promoting health care interventions to health promoters. J Eval Clin Pract. 2000; 
6(4):345–357. [PubMed: 11133118] 
22. Harris JK. Communication ties across the national network of local health departments. American 
Journal of Preventive Medicine. 2013; 44(3):247–253. [PubMed: 23415121] 
23. Pankratz M, Hallfors D, Cho H. Measuring perceptions of innovation adoption: The diffusion of a 
federal drug prevention policy. Health Educ Res. 2002; 17(3):315–326. [PubMed: 12120847] 
24. Goldman KD. Perceptions of innovations as predictors of implementation levels: The diffusion of a 
nation wide health education campaign. Health Education & Behavior. 1994; 21(4):433–445.
25. Plsek PE, Wilson T. Complexity, leadership, and management in healthcare organisations. BMJ. 
2001; 323(7315):746–749. [PubMed: 11576986] 
26. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service 
organizations: Systematic review and recommendations. Milbank Q. 2004; 82(4):581–
629.10.1111/j.0887-378X.2004.00325.x [PubMed: 15595944] 
27. Harris JR, Cheadle A, Hannon PA, et al. A framework for disseminating evidence-based health 
promotion practices. Preventing Chronic Disease. 2012; 9
Harris et al. Page 9
J Public Health Manag Pract. Author manuscript; available in PMC 2015 December 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Average LHD director and manager scores for paired data on the 10 diffusion items. 
Significant differences between directors and managers marked by *.
Harris et al. Page 10
J Public Health Manag Pract. Author manuscript; available in PMC 2015 December 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Harris et al. Page 11
Table 1
Survey items for measuring agreement with diffusion characteristics in local health department directors and 
managers.
Diffusion characteristic Survey item(s)
Relative advantage (1) Positive changes in my agency can occur as a result of EBDM
Compatibility (2) EBDM fits with my agency's mission or goals
(3) EBDM is consistent with what we're already doing as an agency
Simplicity (4) In my agency, EBDM is easy to understand
(5) In my agency, EBDM is easy to implement
Testability (6) Components of an EBDM process can be subdivided in order to implement them
(7) EBDM has minimal financial cost to implement
(8) We would have to make many changes in my agency to implement EBDM
(9) We would have to hire new staff or retrain staff to implement EBDM
(10) Components of EBDM can be implemented or tried without fully committing to the entire process
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